Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Scientists use inactive virus to safe-deliver spasticity-reversing spinal genes

9

Jun 2026

Scientists use inactive virus to safe-deliver spasticity-reversing spinal genes

Muscle spasticity is a common and often debilitating consequence of spinal cord injury that can significantly affect mobility and quality of life. Spasticity is a condition in which muscles become abnormally stiff or tight because of disrupted nerve signaling, often causing exaggerated reflexes, involuntary muscle spasms and difficulty with movement.

New non-invasive tool lowers cancer DNA tracking threshold to 5%

9

Jun 2026

New non-invasive tool lowers cancer DNA tracking threshold to 5%

Blood tests have proved to be a promising tool for detecting and monitoring cancer. Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have now developed a new method that makes it possible to analyze samples containing as little as 5 per cent cancer DNA in the blood, compared with the 15–20 per cent required today. This method could lead to better cancer care and improved monitoring of tumor progression.

Cellular map of healthy pancreas reveals origins of deadly tumors

9

Jun 2026

Cellular map of healthy pancreas reveals origins of deadly tumors

Scientists at the Free University of Brussels (VUB) have taken a major step forward in pancreatic cancer research. By mapping a healthy pancreas in detail down to the cellular level, they discovered that specific, rare cells in the healthy organ already bear strong similarities to the most aggressive tumor cells.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.